Almudena González-Domínguez

5PUBLICATIONS
7CO-AUTHORS
Molecular targetsUrban and regional economicsCardiology (incl. cardiovascular diseases)Respiratory diseasesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 19, 2024
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain.

Sergio Cedillo, Almudena González-Domínguez, Yoana Ivanova-Markova

|Jun 12, 2021
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain.

Alejandro Soriano, Rocío Montejano, José Sanz-Moreno

|Oct 19, 2020
Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain.

Juan F Delgado, Juan Oliva, Álvaro González-Franco

|Oct 08, 2020
Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review.

Josep Comín-Colet, Teresa Martín Lorenzo, Almudena González-Domínguez

|Jan 09, 2019
Cost-utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain.

Carlota Moya-Alarcón, Almudena González-Domínguez, Susana Simon

Pageof 1